Literature DB >> 16953951

Hepatitis C virus: laboratory surveillance in England and Wales, 1992-2004.

U Gungabissoon1, M A Balogun, M E Ramsay.   

Abstract

Between 1992 and 2004, a total of 49,819 confirmed hepatitis C infections have been reported to the Health Protection Agency (HPA) by laboratories in England and Wales; the annual number of reports increased from 241 in 1991 to 8149 in 2004. Most reports with a known risk factor were in injecting drug users (87%, 12,438/14,221), but 71% (35,598/49,819) of the total had no reported identified risk. The age-sex distribution of the latter cases was similar to that in injecting drug users. Using names to assign ethnicity, individuals with South Asian names had an older age distribution and a different risk factor profile from non-South Asians. Using published age-specific prevalence data from 1996, it was estimated that around 28,1764 cases of hepatitis C infection exist in England and Wales, and that only 17% of these cases have been reported to the HPA. Surveillance reports continue to provide important information regarding trends in hepatitis C infection in specific risk groups.

Entities:  

Mesh:

Year:  2006        PMID: 16953951      PMCID: PMC2870602          DOI: 10.1017/S0950268806007138

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  32 in total

1.  The scientific challenge of hepatitis C.

Authors:  J Cohen
Journal:  Science       Date:  1999-07-02       Impact factor: 47.728

2.  The potential to identify South Asians using a computerised algorithm to classify names.

Authors:  S Harding; H Dews; S L Simpson
Journal:  Popul Trends       Date:  1999

Review 3.  Mother-to-infant transmission of hepatitis C virus.

Authors:  L T Yeung; S M King; E A Roberts
Journal:  Hepatology       Date:  2001-08       Impact factor: 17.425

4.  Hepatitis B and hepatitis C virus infections: risk factors among drug users in Northwest England.

Authors:  K H Lamden; N Kennedy; N J Beeching; D Lowe; C L Morrison; H Mallinson; K J Mutton; Q Syed
Journal:  J Infect       Date:  1998-11       Impact factor: 6.072

5.  Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and acceptability of named antenatal testing.

Authors:  C Ward; G Tudor-Williams; T Cotzias; S Hargreaves; L Regan; G R Foster
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

6.  The prevalence and genetic diversity of hepatitis C infection in antenatal clinic attenders in two regions of England.

Authors:  M A Balogun; M E Ramsay; J V Parry; L Donovan; N J Andrews; J A Newham; S Cliffe; K A Harris; C G Teo
Journal:  Epidemiol Infect       Date:  2000-12       Impact factor: 2.451

7.  Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium.

Authors: 
Journal:  J Viral Hepat       Date:  1999-01       Impact factor: 3.728

8.  Sharing of drug preparation equipment as a risk factor for hepatitis C.

Authors:  H Hagan; H Thiede; N S Weiss; S G Hopkins; J S Duchin; E R Alexander
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

Review 9.  Hepatitis C: an epidemiological review.

Authors:  M I Memon; M A Memon
Journal:  J Viral Hepat       Date:  2002-03       Impact factor: 3.728

10.  Risk factors, clinical features and genotype distribution of diagnosed hepatitis C virus infections: a pilot for a sentinel laboratory-based surveillance.

Authors:  M A Balogun; H Laurichesse; M E Ramsay; J Sellwood; D Westmoreland; W K Paver; S F Pugh; M Zuckerman; D Pillay; T Wreghitt
Journal:  Commun Dis Public Health       Date:  2003-04
View more
  5 in total

1.  Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infection.

Authors:  L J Brant; M Hurrelle; M A Balogun; P Klapper; F Ahmad; E Boxall; A Hale; V Hollyoak; I B Ibrahim; W Irving; R Meigh; K J Mutton; B C Patel; W K Paver; S Pugh; C Taylor; A J Turner; M E Ramsay
Journal:  Epidemiol Infect       Date:  2006-07-13       Impact factor: 2.451

2.  Cancer incidence in British Indians and British whites in Leicester, 2001-2006.

Authors:  R Ali; I Barnes; S W Kan; V Beral
Journal:  Br J Cancer       Date:  2010-06-15       Impact factor: 7.640

3.  Use of laboratory-based surveillance data to estimate the number of people chronically infected with hepatitis B living in Scotland.

Authors:  C Schnier; L Wallace; K Tempelton; C Aitken; R N Gunson; P Molyneaux; P McINTYRE; C Povey; D Goldberg; S Hutchinson
Journal:  Epidemiol Infect       Date:  2013-12-17       Impact factor: 4.434

4.  Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study.

Authors:  Qiushi Chen; Turgay Ayer; Emily Bethea; Fasiha Kanwal; Xiaojie Wang; Mark Roberts; Yueran Zhuo; Stefano Fagiuoli; Jorg Petersen; Jagpreet Chhatwal
Journal:  BMJ Open       Date:  2019-06-11       Impact factor: 2.692

5.  Estimating the number of injecting drug users in Scotland's HCV-diagnosed population using capture-recapture methods.

Authors:  S A McDonald; S J Hutchinson; C Schnier; A McLeod; D J Goldberg
Journal:  Epidemiol Infect       Date:  2013-03-22       Impact factor: 4.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.